The American Society of Addiction Medicine and the American Medical Association yesterday released an issue brief on an alternative payment model for medication-assisted therapy, and seek physician practices and insurers interested in pilot testing the model for patients with opioid use disorder. “While we know that a combination of medication and psychosocial support systems is the evidence-based standard for treatment, we continue to find that patients are not able to access treatment due to limited or non-existent insurance coverage,” said Shawn Ryan, M.D., chair of the AMA-ASAM working group that developed the framework for the model, called Patient-Centered Opioid Addiction Treatment (P-COAT). “We hope that today’s announcement will begin a national conversation with insurers and policymakers about what it takes for successful treatment and recovery.” AHA also is developing a strategy to treat substance use disorders as part of its work to advance new payment models, which includes working with the Alliance for Recovery-centered Addiction Health Services to design a system of care for SUD screening, treatment and recovery that incentivizes recovery, not relapse, for alcohol and opioid use disorders. AHA members participating in the Alliance, which expects to release more information on its model this summer, include Carroll Hospital Center in Westminster, MD; Intermountain Healthcare in Salt Lake City; Johns Hopkins Medicine in Baltimore; Partners HealthCare in Boston; and UCSF Health in San Francisco.

Related News Articles

Headline
The AHA’s Association for Health Care Resource & Materials Management (AHRMM) has named as its new executive director Mike Schiller, who has served as…
Headline
AHA March 18 shared with the House Ways and Means Committee its proposals to strengthen access to timely emergency medical care, particularly in rural and…
Headline
AHA March 12 released a new report from Healthsperien on discounts to 340B hospitals through the 340B Drug Pricing Program relative to drug company revenues…
Headline
The U.S. Court of Appeals for the 8th Circuit March 12 upheld Arkansas’ 340B Drug Pricing Nondiscrimination Act against a constitutional challenge brought by…
Headline
Jill Howard, R.N., senior consultant, Sheppard Pratt Solutions, is the 2024 chair of AHA’s Committee on Behavioral Health. Zelia Baugh, executive vice…
Headline
AHA Feb. 29 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B…